Fig. 2From: Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivoAntitumor activity of AsIII alone and in combination with Tetra in MDA-MB-231 mouse xenografts. The experiment was carried out using human breast cancer nude mice implanted subcutaneously with 1 × 107 MDA-MB-231 cells. The administration of AsIII and Tetra, alone or in combination, was performed as described under “Materials and methods”. Tumor volumes (a) and body weights (b) were measured at indicated time points, respectively. Tumor weights at time of sacrifice (c), and photographs of isolated tumors derived from vehicle-control and treated mice (d) were presented. *p < 0.05, ‡p < 0.01 vs. vehicle-control (treated with PBS). As, AsIII; Tetra, tetrandrine; As + Tetra, AsIII + tetrandrineBack to article page